ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

BNTC Benitec Biopharma Limited

7,99
-0,33 (-3,97%)
08 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Benitec Biopharma Limited BNTC NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,33 -3,97% 7,99 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
8,21 8,01 8,28 8,15 8,32
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.3.202422:17EDGAR2Form 8-K - Current report
08.3.202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
26.2.202415:06EDGAR2Form DEL AM - Delaying amendment
23.2.202422:09EDGAR2Form S-3 - Registration statement under Securities Act of..
13.2.202414:15EDGAR2Form 8-K - Current report
13.2.202414:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.12.202322:15EDGAR2Form 8-K - Current report
30.11.202313:31EDGAR2Form 8-K - Current report
17.11.202314:00GLOBEBenitec Biopharma to Participate in a Fireside Chat at the..
13.11.202314:03EDGAR2Form 8-K - Current report
13.11.202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202314:00GLOBEBenitec Biopharma Releases First Quarter 2024 Financial..
20.10.202322:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20.10.202312:04EDGAR2Form DEF 14A - Other definitive proxy statements
16.10.202323:29EDGAR2Form 8-K - Current report
28.9.202323:19EDGAR2Form 8-K - Current report
21.9.202314:05EDGAR2Form 8-K - Current report
21.9.202314:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21.9.202314:00GLOBEBenitec Biopharma Releases Full Year 2023 Financial Results..
18.9.202323:26EDGAR2Form 8-K - Current report
14.8.202323:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202322:01EDGAR2Form 8-K - Current report
11.8.202319:00GLOBEBenitec Biopharma Inc. Announces Closing of $30 Million..
10.8.202322:42EDGAR2Form 8-K - Current report
10.8.202322:06EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
09.8.202304:30GLOBEBenitec Biopharma Inc. Announces Pricing of $30 Million..
07.8.202314:11EDGAR2Form S-1/A - General form for registration of securities..
03.8.202314:27EDGAR2Form S-1/A - General form for registration of securities..
31.7.202314:34EDGAR2Form S-1/A - General form for registration of securities..
25.7.202320:08EDGAR2Form 8-K - Current report
25.7.202319:00GLOBEBenitec Biopharma Announces 1-for-17 Reverse Stock Split..
07.7.202322:52EDGAR2Form S-1 - General form for registration of securities under..
26.6.202314:00GLOBEBenitec Biopharma Receives FDA Clearance of the IND for..
15.5.202314:00GLOBEBenitec Biopharma Releases Third Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock